Regulations.gov document
Informed Consent: Guidance for Institutional Review Boards, Clinical Investigators, and…
Notice · FDA-2006-D-0031 · posted Aug 16, 2023
Key facts
| Document ID | FDA-2006-D-0031-0138 |
|---|---|
| Title | Informed Consent: Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2006-D-0031 |
| Posted | Aug 16, 2023 |
| Federal Register citation | 88 FR 55703 |
| FR document number | 2023-17594 |
| Comment period opens | Aug 16, 2023 |
| Effective date | Aug 16, 2023 |
At a glance
- 1–9 Pages
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: